Medrx announced a sales partnership with Terrain for Bondlido in the US. The launch timing is expected to be disclosed in a future timely disclosure.
Medrx announced that it had entered into a sales partnership with Terrain for Bondlido in the US market. The agreement is intended to accelerate its sales rollout and preparations for the product's market launch there. Cooperation on local distribution arrangements and promotional activities may have been included among the agreed terms, and attention is expected to focus on developments in implementation.
No specific date for the launch was included in the published materials, and it is expected to be provided in a future timely disclosure. Developments in the partnership and the latest information on local regulatory matters will be closely watched.